Regulus Appoints VP, Investor Relations And Corporate Communications
Regulus Therapeutics Inc. has appointed Allison Wey vice president, investor relations and corporate communications. Wey brings over 25 years of experience in investor and media relations to the biopharma company, which specialises in medicines targeting microRNAs. She was previously vice president, investor relations at Durata Therapeutics, before which she held senior roles at Par Pharmaceuticals, Boron LePore and Associates and Edelman Financial Worldwide.
Register for our free email digests: